Noveris Health Sciences Inc. (CSE:NVRS)
Canada · Delayed Price · Currency is CAD 0.4150
+0.0700 (20.29%)
At close: Aug 10, 2026
Noveris Health Sciences Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
20.20M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 7.49K | 4.88K | 186.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Noveris Health Sciences News
- 4 days ago - Noveris Health Sciences Inc. Unaware of Any Material Change - Newsfile Corp
- 11 days ago - Noveris Health Sciences Joins BioAlberta - Newsfile Corp
- 24 days ago - Noveris Health Sciences Joins the Biotechnology Innovation Organization (BIO) - TheNewswire
- 27 days ago - Noveris Health Sciences Joins Life Sciences BC - TheNewswire
- 6 weeks ago - Noveris Health Sciences Announces Upcoming AGM and Record Date, and receipt of CSE Notice - TheNewswire
- 2 months ago - Noveris Health Sciences Announces Appointment Of Nathan Mison As Chair Of Advisory Board - TheNewswire
- 2 months ago - Noveris Health Sciences Appoints Geoff Griffiths As Strategic Advisor To Support Commercialization And Growth Initiatives - TheNewswire
- 2 months ago - Noveris Health Sciences Provides Corporate Update - TheNewswire